Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for Toll- like receptors 2
Most Correlated Studies
- Synthetic TLR ligands affects as aerosol treatment on lung expression
- Whole blood of IRAK4-null, MYD88-null and normal donors treated with Toll-like receptor agonists
- Gastric cancer cells treated with Toll-like receptor(TLR) ligand Pam3Cys-Ser-(Lys)4 and FSL-1
- B cell-like diffuse large B cell lymphoma TMD8 cells with TLR7 or TLR9 shRNA knockdown
- Skin of mice with IL23-induced psoriasis-like phenotype treated with TLR7/8/9 antagonists
Most Relevant Literature
- Structure based design and synthesis of novel Toll-like Receptor 2 (TLR 2) lipid antagonists.
- Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy.
- TLR2-mediated innate immune priming boosts lung anti-viral immunity.
- Leishmania mexicana Lipophosphoglycan Activates Dermal γδ T Cells with Participation of TLR2.
- FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans.
Most Relevant Clinical Trials
- Expression of Toll-Like Receptors 2 and 4 in Asthmatic Patients.
- A Phase I, 2-part (Part 1 Being a Single Dose Escalation and Part 2, a Parallel Group) Study of Toll…
- Oral Vitamin D and Toll Like Receptor in Spondylitis Tuberculosis
- Plasmacytoid Dendritic Cells and Toll Like Receptor 8 in Systemic Sclerosis
- A Multipeptide Vaccine Plus Toll-Like Receptor Agonists in Melanoma Patients
